Skip to main navigation

Patients & Families
Healthcare Providers
Investors & Media

Our Science
Our Pipeline
Our Company
Our Partnerships
Life at C4T

Our Science
Our Pipeline
- Overview
- Cemsidomide
- CFT8634
- CFT8919
Our Partnerships
Who We Are
Life at C4T

Patients & Families
Healthcare Providers
Investors & Media

Overview
Press Releases
Events & Presentations
Stock Information
Analyst Coverage
SEC Filings
Corporate Governance
Email Alerts
Contact IR
FAQs

Overview

Featured Menu

Our Corporate Presentation
Our Latest 10-K
Our Scientific Publications
Sign up for email alerts

Press Releases

C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma

Mar 25, 2026

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mar 9, 2026

C4 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Feb 26, 2026

View All News

View all press releases

Upcoming Events

More events are coming soon.

Past Events

Barclays 28th Annual Global Healthcare Conference

Mar 10, 2026 8:00 AM EDT

TD Cowen 46th Annual Healthcare Conference

Mar 3, 2026 11:50 AM EST

Supporting Materials

TD Cowen 46th Annual Healthcare Conference Presentation 1.1 MB

Guggenheim Emerging Outlook: Biotech Summit 2026

Feb 11, 2026 11:30 AM EST

View all events

View all of our past events

Change

Volume

52 Week High

52 Week Low

Mar 31, 2026 10:55 PM EDT

Image Description

617-231-0700
info@c4therapeutics.com

490 Arsenal Way, Suite 120
Watertown, MA 02472

© 2026 C4 Therapeutics, Inc., Inc.

Privacy Policy
Terms of Use Agreement

You are now leaving c4therapeutics.com

You are about to leave C4 Therapeutics, Inc. (C4T)'s website. This link will take you to an independent website that C4T does not control and to which our Privacy Policy does not apply. C4T is not responsible for the privacy practices or content of any third party websites. We encourage you to read the applicable privacy policies and terms of use of such websites prior to using them.

No, I want to stay Yes, I want to Proceed to the Other Site

You are now leaving c4therapeutics.com

You are about to leave C4 Therapeutics, Inc. (C4T)'s website. This link will take you to an independent website that C4T does not control and to which our Privacy Policy does not apply. C4T is not responsible for the privacy practices or content of any third party websites. We encourage you to read the applicable privacy policies and terms of use of such websites prior to using them.

No, I want to stay Yes, I want to Proceed to the Other Site